Omega Diagnostics Ltd

Omega Diagnostics Ltd is a company that specializes in the development and manufacture of innovative diagnostic tests for the healthcare industry. With a focus on improving human health and well-being, the company provides specialist products, primarily in the immunoassay and in-vitro diagnostics market. Omega Diagnostics Ltd's products and services include food intolerance tests, such as Food Detective and Food Print, as well as the VISITECT CD4 rapid test for HIV diagnosis. The company's partnership with the Burnet Institute and its involvement in the UK Rapid Test Consortium demonstrate its commitment to developing and delivering high-quality diagnostic solutions that make a positive impact on people's lives.

Our mission is to improve human health and well-being through innovative diagnostic tests and global partnerships. Omega is focused on providing specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within Health & Wellbeing and Global Health.

In Health & Wellbeing, through Cambridge Nutritional Sciences (CNS), we are empowering individuals to take control of their health by offering a range of food intolerance tests: Food Detective® (point-of-care), ELISA, Food Print® (Microarray) and CNS Lab Service.

Omega’s Global Health Division partnered with the Burnet Institute to deliver a worlds first in VISITECT® CD4, a rapid, convenient and affordable test for CD4 in people living with HIV. The test can be used in decentralised locations and is aimed at improving access to essential diagnostics in low- and middle-income countries.

Omega Diagnostics is part of the UK Rapid Test Consortium ("UK-RTC") to jointly develop and manufacture a COVID-19 point-of-care antibody test as part of the UK Government's five pillar national testing strategy for COVID-19.

Global Health
Focus on unique VISITECT® CD4 rapid tests enabling access to people living with HIV in low- and middle-income countries

Food Intolerance
Point-of-care and laboratory-based solutions for food intolerance and gut health

COVID-19
We are meeting the demand for both point-of-care and laboratory-based tests for COVID-19 diagnostics